UPDATE: TransMedics Group (TMDX) Prices 5M Share Common Offering at $14/Sh

TransMedics Group, Inc. (NASDAQ: TMDX) announced today the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share. All of the shares are being offered by TransMedics.

The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by TransMedics, are expected to be $70.0 million. The offering is expected to close on May 29, 2020, subject to the satisfaction of customary closing conditions. In addition, TransMedics has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the public offering price, less underwriting discounts and commissions.

J.P. Morgan and Morgan Stanley are acting as joint lead book-running managers for the offering. Canaccord Genuity is acting as lead manager for the offering.

You May Also Be Interested In

• Amylyx prices $500M stock offering at $35.50 per share
• JPMorgan Reiterates Overweight Rating on Marvell (MRVL)
• Morgan Stanley Upgrades Merck (MRK) to Overweight